|
| Patient | Age/Sex | Diagnosis | Surgical procedure | Neoadjuvant chemotherapy | Pathology (TNM) | Category |
|
| A | 49/M | Ductal adenocarcinoma pancreatic body | Distal pancreatectomy, splenectomy,
celiac trunk resection,
portal vein wedge resection | No | pT2 pN1 (2/24) L1 V1 Pn1 G3 | R1 |
|
| B | 66/M | Ductal adenocarcinoma
pancreatic head | PPPD,
portal vein wedge resection | No | pT2 pN1 (3/21) L1 V0 Pn1 G2 | R1 |
|
| C | 82/M | IPMC | PPPD,
portal vein wedge resection | No | pT1c pN0 (0/28) L0 V0 Pn0 G2 | R0 |
|
| D | 63/M | Ductal adenocarcinoma
pancreatic body | Distal pancreatectomy, splenectomy,
celiac trunk resection,
portal vein wedge resection | No | pT2 pN0 (0/11) L0 V1 Pn1 G2 | R1 |
|
| E | 58/F | Ductal adenocarcinoma
pancreatic tail | Distal pancreatectomy, splenectomy,
Portal vein segment resection | Yes
FOLFIRINOX (6#) | ypT2 ypN0 (0/11) L0 V1 Pn1 G2 | R1 |
|
| F | 65/F | Ductal adenocarcinoma
pancreatic body | Distal pancreatectomy, splenectomy,
Portal vein wedge resection | No | pT2 pN2 (5/48) L0 V1 Pn1 G3 | R1 |
|
| G | 70/M | Ductal adenocarcinoma
pancreatic head | Pylorus preservation pancreatectomy,
portal vein wedge resection | Yes
FOLFIRINOX (10#) | ypT2 ypN2 (4/24) L0 V0 Pn0 G2 | R0 |
|
| H | 63/F | Ductal adenocarcinoma
pancreatic head | Pylorus preservation pancreatectomy,
portal vein wedge resection | Yes
FOLFIRINOX (6#) | ypT3 ypN1 (1/17) L0 V0 Pn1 G2 | R1 |
|
| I | 72/F | Ductal adenocarcinoma
pancreatic head | PPPD,
portal vein wedge resection | No | pT3 pN1(1/12) L0 V1 Pn1 G2 | R1 |
|
| J | 43/F | Ductal adenocarcinoma
pancreatic head | PPPD,
portal vein segment resection | No | pT2 pN0 (0/14) L0 V0 Pn1 G2 | R0 |
|
| K | 63/M | Ductal adenocarcinoma
pancreatic head | PPPD,
portal vein wedge resection | No | pT3 N0 (0/28) R0 L0 V0 Pn1 G3 | R0 |
|
